Ironwood Pharmaceuticals Inc (IRWD)
8.62
+0.30
(+3.61%)
USD |
NASDAQ |
Mar 27, 16:00
8.615
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Enterprise Value: 1.955B for March 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 27, 2024 | 1.955B |
March 26, 2024 | 1.908B |
March 25, 2024 | 1.922B |
March 22, 2024 | 1.964B |
March 21, 2024 | 2.019B |
March 20, 2024 | 2.032B |
March 19, 2024 | 1.991B |
March 18, 2024 | 1.938B |
March 15, 2024 | 2.018B |
March 14, 2024 | 2.010B |
March 13, 2024 | 1.958B |
March 12, 2024 | 1.966B |
March 11, 2024 | 2.007B |
March 08, 2024 | 2.016B |
March 07, 2024 | 2.004B |
March 06, 2024 | 1.955B |
March 05, 2024 | 2.065B |
March 04, 2024 | 2.066B |
March 01, 2024 | 2.025B |
February 29, 2024 | 2.082B |
February 28, 2024 | 2.972B |
February 27, 2024 | 2.982B |
February 26, 2024 | 2.958B |
February 23, 2024 | 2.965B |
February 22, 2024 | 2.932B |
Date | Value |
---|---|
February 21, 2024 | 2.976B |
February 20, 2024 | 2.927B |
February 16, 2024 | 2.888B |
February 15, 2024 | 2.952B |
February 14, 2024 | 3.024B |
February 13, 2024 | 2.985B |
February 12, 2024 | 3.012B |
February 09, 2024 | 3.004B |
February 08, 2024 | 2.938B |
February 07, 2024 | 2.933B |
February 06, 2024 | 2.933B |
February 05, 2024 | 2.915B |
February 02, 2024 | 2.889B |
February 01, 2024 | 2.891B |
January 31, 2024 | 2.827B |
January 30, 2024 | 2.763B |
January 29, 2024 | 2.757B |
January 26, 2024 | 2.699B |
January 25, 2024 | 2.724B |
January 24, 2024 | 2.687B |
January 23, 2024 | 2.713B |
January 22, 2024 | 2.660B |
January 19, 2024 | 2.587B |
January 18, 2024 | 2.510B |
January 17, 2024 | 2.538B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.225B
Minimum
May 16 2023
3.024B
Maximum
Feb 14 2024
1.857B
Average
1.812B
Median
Enterprise Value Benchmarks
Societal CDMO Inc | 144.07M |
Ampio Pharmaceuticals Inc | -5.467M |
Inari Medical Inc | 2.632B |
Kineta Inc | 0.7426M |
Moderna Inc | 33.75B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.087M |
Revenue (Quarterly) | 117.55M |
Total Expenses (Quarterly) | 74.34M |
EPS Diluted (Quarterly) | -0.01 |
Profit Margin (Quarterly) | -0.92% |
Earnings Yield | -75.52% |
Operating Earnings Yield | 11.40% |
Normalized Earnings Yield | -9.872 |